SEARCH

SEARCH BY CITATION

References

  • Agorastos, T., Karavida, A., Lambropoulos, A., Constantinidis, T., Tzitzimikas, S. & Chrisafi, S. (2002) Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. Journal of Maternal–Fetal and Neonatal Medicine, 12, 267273.
  • Alfirevic, Z., Mousa, H.A., Martlew, V., Briscoe, L., Perez-Casal, M. & Toh, C.H. (2001) Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstetrics and Gynecology, 97 (5:Pt 1), 0t-9.
  • Alfirevic, Z., Roberts, D. & Martlew, V. (2002) How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. European Journal of Obstetric and Gynaecological Reproductive Biology, 101, 614.
  • Allen, J.Y., Tapia-Santiago, C. & Kutteh, W.H. (1996) Antiphospholipid antibodies in patients with preeclampsia. American Journal of Reproductive Immunology (Copenhagen), 36, 8185.
  • Alonso, A., Soto, I., Urgelles, M.F., Corte, J.R., Rodriguez, M.J. & Pinto, C.R. (2002) Acquired and inherited thrombophilia in women with unexplained fetal losses. American Journal of Obstetrics and Gynecology, 187, 337342.
  • Balasch, J., Reverter, J.C., Fabregues, F., Tassies, D., Rafel, M. & Creus, M. (1997) First-trimester repeated abortion is not associated with activated protein C resistance. Human Reproduction, 12, 10941097.
  • Bare, S.N., Poka, R., Balogh, I. & Ajzner, E. (2000) Factor V Leiden as a risk factor for miscarriage and reduced fertility. Australian and New Zealand Journal of Obstetrics and Gynecology, 40, 186190.
  • Benedetto, C., Marozio, L., Salton, L., Maula, V., Chieppa, G. & Massobrio, M. (2002) Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome. Acta Obstetricia et Gynecologica Scandinavia, 81, 10951100.
  • Bocciolone, L., Meroni, P., Parazzini, F., Tincani, A., Radici, E. & Tarantini, M. (1994) Antiphospholipid antibodies and risk of intrauterine late fetal death. Acta Obstetricia et Gynecologica Scandinavica, 73, 389392.
  • Brenner, B., Hoffman, R., Carp, H., Dulitsky, M. & Younis, J., for the LIVE-ENOX investigators (2005) Efficacy and safety of two doses of enoxaparin in women with thrombophila and recurrent pregnancy losses: the LIVE-ENOX study. Journal of Thrombosis and Haemostasis, 3, 227229.
  • Carp, H., Salomon, O., Seidman, D., Dardik, R., Rosenberg, N. & Inbal, A. (2002) Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Human Reproduction, 17, 16331637.
  • Chakrabarti, S., Bhunia, C. & Bhattacharya, D.K. (1999) The prevalence of antiphospholipid antibodies in cases of recurrent pregnancy loss. The Journal of the Association of Physicians of India, 47, 496498.
  • Currie, L., Peek, M., McNiven, M., Prosser, I., Mansour, J. & Ridgway, D. (2002) Is there an increased maternal-infant prevalence of Factor V Leiden in association with severe pre-eclampsia? British Journal of Obstetrics and Gynaecology, 109, 191196.
  • D'Elia, A.V., Driul, L., Giacomello, R., Colaone, R., Fabbro, D. & Di Leonardo, C. (2002) Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia. Gynecological and Obstetrical Investigation, 53, 8487.
  • Das, I., Vasishta, K. & Dash, S. (1991) Study of lupus anticoagulant in pregnant women with recurrent abortion. Australian and New Zealand Journal of Obstetrics and Gynecology, 31, 323326.
  • De Carolis, S., Caruso, A., Ferrazzani, S., Carducci, B., De Santis, L. & Mancuso, S. (1994) Poor pregnancy outcome and anticardiolipin antibodies. Fetal Diagnostic Therapy, 9, 296299.
  • Department of Health Welsh Office Scottish Home and Health Department and Department of Health and Social Services Northern Ireland (1998) Confidential Enquiries into Maternal Deaths in the United Kingdom 1994–1997. TSO, London.
  • DerSimonian, R. & Laird, N. (1986) Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177188.
  • Dilley, A., Austin, H., El Jamil, M., Hooper, W.C., Barnhart, E. & Evatt, B.L. (2000) Genetic factors associated with thrombosis in pregnancy in a United States population. American Journal of Obstetrics and Gynecology, 183, 12711277.
  • Dizon-Townson, D.S., Nelson, L.M., Easton, K. & Ward, K. (1996) The factor V Leiden mutation may predispose women to severe preeclampsia. American Journal of Obstetrics and Gynecology, 175(Pt 1), t-5.
  • Dreyfus, M., Hedelin, G., Kutnahorsky, R., Lehmann, M., Viville, B., Langer, B., (2001) Antiphospholipid antibodies and preeclampsia: a case-control study. Obstetrics and Gynecology, 97, 2934.
  • Egger, M., Juni, P., Bartlett, C., Holenstein, F. & Sterne, J. (2003) How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technology Assessment, 7, 176.
  • Empson, M., Lassere, M., Craig, J.C. & Scott, J.R. (2002) Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstetrics and Gynecology, 99, 135144.
  • Farquharson, R.G., Quenby, S. & Greaves, M. (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstetrics and Gynecology, 100, 408413.
  • Fatini, C., Gensini, F., Battaglini, B., Prisco, D., Cellai, A.P. & Fedi, S. (2000) Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. Blood Coagulation and Fibrinolysis, 11, 657662.
  • Finan, R.R., Tamim, H., Ameen, G., Sharida, H.E., Rashid, M. & Almawi, W.Y. (2002) Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. American Journal of Haematology, 71, 300305.
  • Foka, Z.J., Lambropoulos, A.F., Saravelos, H., Karas, G.B., Karavida, A. & Agorastos, T. (2000) Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Human Reproduction, 15, 458462.
  • Franco, R.F., Araujo, A.G., Guerreiro, J.F., Elion, J. & Zago, M.A. (1998) Analysis of the 677 CT mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thrombosis and Haemostasis, 77, 466471.
  • Franklin, R.D. & Kutteh, W.H. (2002) Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Human Reproduction, 17, 29812985.
  • Gates, S. (2000) Thromboembolic disease in pregnancy. Current Opinion in Obstetrics and Gynecology, 12, 117122.
  • Gerhardt, A., Scharf, R.E., Beckmann, M.W., Struve, S., Bender, H.G. & Pillny, M. (2000) Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. New England Journal of Medicine, 342, 374380.
  • Ghee, C.B. & Burrows, R.F. (2002) Prothrombin G20210A mutation is not associated with recurrent miscarriages. Australian and New Zealand Journal of Obstetrics and Gynecology, 42, 167169.
  • Goddijn-Wessel, T.A.W., Wouters, M.G.A.J., Molen, E.F., Spuijbroek, M.D.E.H., Steegers-Theunissen, R.P.M. & Blom, H.J. (1996) Hyperhomocysteinemia: a risk factor for placental abruption or infarction. European Journal of Obstetrics, Gynecology and Reproductive Biology, 66, 2329.
  • Gompel, A., Levy, D.P. & Conard, J. (2002) Ovarian hyperstimulation and thrombosis. In: Women's Issues Thrombosis and Haemostasis, pp. 143150. Martin Dunitz, London.
  • Grandone, E., Margaglione, M., Colaizzo, D., Ad'Addedda, M., Cappucci, G. & Vecchione, G. (1997a) Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thrombosis and Haemostasis, 77, 822824.
  • Grandone, E., Margaglione, M., Colaizzo, D., Cappucci, G., Paladini, D. & Martinelli, P. (1997b) Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thrombosis and Haemostasis, 77, 10521054.
  • Grandone, E., Margaglione, M., Colaizzo, D., D'Andrea, G., Cappucci, G. & Brancaccio, V. (1998) Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. American Journal of Obstetrics and Gynecology, 179, 13241328.
  • Grandone, E., Margaglione, M., Colaizzo, D., Cappucci, G., Scianname, N. & Montanaro, S. (1999) Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria. Thrombosis and Haemostasis, 81, 349352.
  • Greer, I.A. (2003) Thrombophilia: implications for pregnancy outcome. Thrombosis Research, 2152, 19.
  • Gris, J.C., Quere, I., Monpeyroux, F., Mercier, E., Ripart-Neveu, S. & Tailland, M.L. (1999) Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent – the Nimes Obstetricians and Haematologists Study 5 (NOHA5). Thrombosis and Haemostasis, 81, 891899.
  • Gris, J.C., Mercier, E., Quere, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E. & Hoffet, M. (2004) Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood, 103, 36953699.
  • de Groot, C.J., Bloemenkamp, K.W., Duvekot, E.J., Helmerhorst, F.M., Bertina, R.M. & Van Der, M.F. (1999) Preeclampsia and genetic risk factors for thrombosis: a case-control study. American Journal of Obstetrics and Gynecology, 181, 975980.
  • Hatzis, T., Cardamakis, E., Drivalas, E., Makatsoris, K., Bevan, D. & Pantos, C. (1999) Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factors. European Journal of Contraceptive and Reproductive Health Care, 4, 135144.
  • Higashino, M., Takakuwa, K., Arakawa, M., Tamura, M., Yasuda, M. & Tanaka, K. (1998) Anti-cardiolipin antibody and anti-cardiolipin beta-2-glycoprotein I antibody in patients with recurrent fetal miscarriage. Journal of Perinatal Medicine, 26, 384389.
  • Higgins, J., Thompson, S., Deeks, J. & Altman, D. (2003) Measuring inconsistency in meta-analyses. British Medical Journal, 327, 557560.
  • Holmes, Z.R., Regan, L., Chilcott, I. & Cohen, H. (1999) The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. British Journal of Haematology, 105, 98101.
  • Infante-Rivard, C., David, M., Gauthier, R. & Rivard, G.E. (1991) Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. New England Journal of Medicine, 325, 1063106.
  • Infante-Rivard, C., Rivard, G.E., Yotov, W.V., Genin, E., Guiguet, M. & Weinberg, C. (2002) Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. New England Journal of Medicine, 347, 1925.
  • Kim, Y.J., Williamson, R.A., Murray, J.C., Andrews, J., Pietscher, J.J. & Peraud, P.J. (2001) Gentic susceptibility to preeclampsia: role of cytosine-to-thymine substitution at nucleotide 677 of the gene for mtheylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine B-synthase, and factor V Leiden mutation. American Journal of Obstetrics and Gynecology, 184, 12111217.
  • Kupferminc, M.J., Eldor, A., Steinman, N., Many, A., Bar-Am, A. & Jaffa, A. (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. New England Journal of Medicine, 340, 913.
  • Kupferminc, M.J., Peri, H., Zwang, E., Yaron, Y., Wolman, I. & Eldor, A. (2000a) High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstetricia et Gynecologica Scandinavia, 79, 963967.
  • Kupferminc, M.J., Fait, G., Many, A., Gordon, D., Eldor, A. & Lessing, J.B. (2000b) Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstetrics and Gynecology, 96, 4549.
  • Kupferminc, M.J., Many, A., Bar-Am, A., Lessing, J.B. & Ascher-Landsberg, J. (2002) Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia. British Journal of Obstetrics and Gynaecology, 109, 13731376.
  • Kutteh, W.H. (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. American Journal of Obstetrics and Gynecology, 174, 15841589.
  • Kutteh, W.H. & Ermel, L.D. (1996) A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. American Journal of Reproductive Immunology, 35, 402407.
  • Lissak, A., Sharon, A., Fruchter, O., Kassel, A., Sanderovitz, J. & Abramovicic, H. (1999) Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss. American Journal of Obstetrics and Gynecology, 181, 126130.
  • Many, A., Elad, R., Yaron, Y., Eldor, A., Lessing, J.B. & Kupferminc, M.J. (2002) Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstetrics and Gynecology, 99(Pt 1), t-7.
  • Martinelli, I., Taioli, E., Cetin, I., Marinoni, A., Gerosa, S. & Villa, M.V. (2000) Mutations in coagulation factors in women with unexplained late fetal loss. New England Journal of Medicine, 343, 10151018.
  • Martinelli, I., Legnani, C., Bucciarelli, P., Grandone, E., De Stefano, V. & Mannucci, P.M. (2001a) Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thrombosis and Haemostasis, 86, 800803.
  • Martinelli, P., Grandone, E., Colaizzo, D., Paladini, D., Scianname, N. & Margaglione, M. (2001b) Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica, 86, 428431.
  • Martinelli, I., De Stefano, V., Taioli, E., Paciaroni, K., Rossi, E. & Mannucci, P.M. (2002) Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thrombosis and Haemostasis, 87, 791795.
  • Meinardi, J.R., Middeldorp, S., de Kam, P.J., Koopman, M.M., van Pampus, E.C. & Hamulyak, K. (1999) Increased risk for fetal loss in carriers of the factor V Leiden mutation. Annals of Internal Medicine, 130, 736739.
  • Mello, G., Parretti, E., Martini, E., Mecacci, F., La Torre, P. & Cioni, R. (1999) Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies. Haemostasis, 29, 197203.
  • Morrison, E.R., Miedzybrodzka, Z.H., Campbell, D.M., Haites, N.E., Wilson, B.J. & Watson, M.S. (2002) Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thrombosis and Haemostasis, 87, 779785.
  • Murphy, R.P., Donoghue, C., Nallen, R.J., D'Mello, M., Regan, C. & Whitehead, A.S. (2000) Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arteriosclerosis Thrombosis and Vascular Biology, 20, 266270.
  • Nagy, B., Toth, T., Rigo, Jr, J., Karadi, I., Romics, L. & Papp, Z. (1998) Detection of factor V Leiden in severe pre-eclamptic Hungarian women. Clinical Genetics, 53, 478481.
  • Nelen, W.L.D.M., van der Molen, E.F., Blom, H.J., Heil, S.G., Steegers, E.A.P. & Eskes, T.K.A.B. (1997) Recurrent early pregnancy loss and genetic-related disturbances in folate and homocysteine metabolism. British Journal of Hospital Medicine, 58, 511513.
  • NHS Centre for Review & Dissemination (2001) Undertaking Systematic Reviews of Research on Effectiveness CRD's Guidance for those Carrying Out or Commissioning Reviews, 2nd edn. University of York, York.
  • O'Shaughnessy, K.M., Fu, B., Ferraro, F., Lewis, I., Downing, S. & Morris, N.H. (1999) Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension, 33, 13381341.
  • Ogasawara, M., Aoki, K., Matsuura, E., Sasa, H. & Yagami, Y. (1996) Anti beta2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance. Lupus, 5, 587592.
  • Ogunyemi, D., Cuellar, F., Ku, W. & Arkel, Y. (2003) Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein a levels and venous thromboembolism in pregnancy. American Journal of Perinatalogy, 1, 1724.
  • Owen, E.P., Human, L., Carolissen, A.A., Harley, E.H. & Odendaal, H.J. (1997) Hyperhomocysteinemia – a risk factor for abruptio placentae. Journal of Inherited Metabolic Disease, 20, 359362.
  • Pabinger, I., Nemes, L., Rintelen, C., Koder, S., Lechler, E. & Loreth, R.M. (2000) Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. Hematology Journal, 1, 3741.
  • Pattison, N.S., Chamley, L.W., Birdsall, M., Zanderigo, A.M., Liddell, H.S. & McDougall, J. (2000) Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. American Journal of Obstetrics Gynecology, 183, 10081012.
  • Pauzner, R., Dulitzki, M., Langevitz, P., Livneh, A., Kenett, R. & Many, A. (2001) Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thrombosis and Haemostasis, 86, 13791384.
  • Pickering, W., Marriott, K. & Regan, L. (2001) G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population. Clinical and Applied Thrombosis and Haemostasis, 7, 2528.
  • Pihusch, R., Buchholz, T., Lohse, P., Rubsamen, H., Rogenhofe, N. & Hasbargen, U. (2001) Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. American Journal of Reproductive Immunology, 46, 124131.
  • Rai, R., Cohen, H., Dave, M. & Regan, L. (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). British Medical Journal, 314, 253257.
  • Rai, R., Shlebak, A., Cohen, H., Backos, M., Holmes, Z. & Marriott, K. (2001) Factor V leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Human Reproduction, 16, 961965.
  • Raijmakers, M.T.M., Zusterzeel, P.L.M., Steegers, E.A.P. & Peters, W.H.M. (2001) Hyperhomocysteinaemia: a risk factor for pre-eclampsia? European Journal of Obstetrics, Gynaecology and Reproductive Biology, 95, 226228.
  • Raziel, A., Kornberg, Y., Friedler, S., Schachter, M., Sela, B.A. & Ron-El, R. (2001) Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. American Journal of Reproductive Immunology (Copenhagen), 45, 6571.
  • Reid, W. & Perry, D.J. (2001) Internal jugular vein thrombosis following in-vitro fertilization in a woman with protein S deficiency and heterozygosity for the prothrombin 3′ UTR mutation, despite anticoagulation with heparin. Blood Coaguation and Fibrinolysis, 12, 487489.
  • Rey, E., Kahn, S.R., David, M. & Shrier, I. (2003) Thrombophilic disorders and fetal loss: a meta-analysis. The Lancet, 361, 901908.
  • Reznikoff-Etievan, M.F., Cayol, V., Carbonne, B., Robert, A., Coulet, F. & Milliez, J. (2001) Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. British Journal of Obstetrics and Gynaecology, 108, 12511254.
  • Rigo, Jr, J., Nagy, B., Fintor, L., Tanyi, J., Beke, A. & Karadi, I. (2000) Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertension in Pregnancy, 19, 163172.
  • Rosendaal, F.R., Doggen, C.J., Zivelin, A., Arruda, V.R., Aiach, M. & Siscovick, D.S. (1998) Geographic distribution of the 20210 G to A prothrombin variant. Thrombosis and Haemostasis, 79, 706708.
  • Rothbart, H., Ohel, G., Younis, J., Lanir, N. & Brenner, B. (1999) High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal death. Journal of Maternal and Fetal Medicine, 8, 228230.
  • Schjetlein, R., Haugen, G., Moe, N., Husby, H. & Wisloff, F. (1998) Preeclampsia and fetal growth retardation: is there an association with antiphospholipid antibodies? Hypertension in Pregnancy, 17, 8192.
  • Scottish Obstetric Guidelines and Audit Project (1998) The Management of Postaprtum Haemorrhage: A Clinical Practice Guideline for Professionals Involved in Maternity Care in Scotland. Scottish Programme for Clinical Effectiveness in Reproductive Health publication number 6. WWW document. URL. http://www.abdn.ac.uk/spcerh/publications/SOGAP%206.pdf.
  • Tal, J., Schliamser, L.M., Leibovitz, Z., Ohel, G. & Attias, D. (1999) A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Human Reproduction, 14, 16241627.
  • Tormene, D., Simioni, P., Prandoni, P., Luni, S., Innella, B. & Sabbion, P. (1999) The risk of fetal loss in family members of probands with factor V Leiden mutation. Thrombosis and Haemostasis, 82, 12371239.
  • Tormene, D., Simioni, P., Prandoni, P., Luni, S., Zerbinati, P. & Sartor, D. (2001) Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women. Haematologica, 86, 13051309.
  • Van Pampus, M.G., Dekker, G.A., Wolf, H., Huijgens, P.C., Koopman, M.M.W. & Von Blomberg, B.M.E. (1999) High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. American Journal of Obstetrics and Gynecology, 180, 11461150.
  • Walker, I.D. (2000a) Thrombophilia in pregnancy. Journal of Clinical Pathology, 53, 573580.
  • Walker, J.J. (2000b) Pre-eclampsia. The Lancet, 356, 12601265.
  • Walker, M.C., Ferguson, S.E. & Allen, V.M. (2005) Heparin for pregnant women with acquired or inherited thrombophilias (review). The Cochrane Library.
  • Wiener-Megnagi, Z., Ben Shlomo, I., Goldberg, Y. & Shalev, E. (1998) Resistance to activated protein C and the leiden mutation: high prevalence in patients with abruptio placentae. American Journal of Obstetrics and Gynecology, 179(Pt 1), t-7.
  • Wouters, M.G., Boers, G.H., Blom, H.J, , Trijbels, F.J., Thomas, C.M. & Borm, G.F. (1993) Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertility and Sterility, 60, 820825.
  • Yasuda, M., Takakuwa, K., Tokunaga, A. & Tanaka, K. (1995) Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstetrics and Gynecology, 86(Pt 1), t-9.
  • Younis, J.S., Brenner, B., Ohel, G., Tal, J., Lanir, N. & Ben Ami, M. (2000) Activated protein C resistance and factor V Leiden mutation can be associated with first- as well as second-trimester recurrent pregnancy loss. American Journal of Reproductive Immunology, 43, 3135.